Compile Data Set for Download or QSAR
Report error Found 35 Enz. Inhib. hit(s) with all data for entry = 10899
TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576653BDBM576653(US11472788, Example A22)
Affinity DataIC50: 10nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576655BDBM576655(US11472788, Example A23b)
Affinity DataIC50: 3.25E+3nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576662BDBM576662(US11472788, Example A34b)
Affinity DataIC50: 4.80E+3nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576649BDBM576649(US11472788, Example A18)
Affinity DataIC50: 5.30E+3nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576665BDBM576665(US11472788, Example A37b)
Affinity DataIC50: 6.90E+3nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576661BDBM576661(US11472788, Example A34a)
Affinity DataIC50: 8.00E+3nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576658BDBM576658(US11472788, Example A32)
Affinity DataIC50: 8.10E+3nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576660BDBM576660(US11472788, Example A33b)
Affinity DataIC50: 8.20E+3nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576634BDBM576634(US11472788, Example A1b)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576635BDBM576635(US11472788, Example A2a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576633BDBM576633(US11472788, Example A1a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576656BDBM576656(US11472788, Example A30a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576654BDBM576654(US11472788, Example A23a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576659BDBM576659(US11472788, Example A33a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576657BDBM576657(US11472788, Example A30b)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576663BDBM576663(US11472788, Example A35)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576664BDBM576664(US11472788, Example A37a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576668BDBM576668(US11472788, Example A40)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576669BDBM576669(US11472788, Example A41)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576666BDBM576666(US11472788, Example A38)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576638BDBM576638(US11472788, Example A4b)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576639BDBM576639(US11472788, Example A6a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576636BDBM576636(US11472788, Example A2b)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576637BDBM576637(US11472788, Example A4a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576643BDBM576643(US11472788, Example A9b)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576644BDBM576644(US11472788, Example A10a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576640BDBM576640(US11472788, Example A6b)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576642BDBM576642(US11472788, Example A9a)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576647BDBM576647(US11472788, Example A13)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576648BDBM576648(US11472788, Example A14)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576645BDBM576645(US11472788, Example A10b)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576646BDBM576646(US11472788, Example A12)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576651BDBM576651(US11472788, Example A20)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576652BDBM576652(US11472788, Example A21)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Beigene

US Patent
LigandChemical structure of BindingDB Monomer ID 576650BDBM576650(US11472788, Example A19)
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant IDO1 was overexpressed and purified from E. coli cells with an N-terminal His tag. IDO1 enzymatic assay was carried out using a methodolo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2022
Entry Details
US Patent